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Abstract: Corneal perforation can cause profound vision loss and requires immediate treatment. Bandage contact lens insertion and
gluing are temporary treatment methods. However, if the patient cannot undergo surgery for a variety of reasons, these methods are
inevitably used as permanent treatment methods. The use of cyanoacrylate tissue adhesive (CTA) for the management of corneal
perforation in humans has been reported for several decades. Here we describe, for the first time as per our knowledge, the use of
CTA (Vetbond) for the management of corneal perforation with a diameter of <3 mm in three dogs. The procedure of application was
simple and only required topical anesthesia. Surgical intervention was not needed in any case, and healing was achieved with repeated
applications of CTA alone. Our findings suggest that CTA application can be safely used for the management of corneal perforation (<3
mm) in dogs that cannot undergo surgery with cosmetic outcomes that are better than those achieved with conventional treatments
(e.g., conjunctival grafts).
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1. Introduction
Since the introduction of n-butyl cyanoacrylate application
for the management of corneal diseases in humans in 1968,
cyanoacrylate derivatives have been used in a number of
ophthalmological surgical procedures in humans, including
the treatment of corneal ulcers and perforations [1].
Ollivier et al. reported a variety of indications for a mixture
of 95% n-butyl 2-cyanoacrylate and 5% cyanoacrylic acid
stained with methylene blue dye [cyanoacrylate tissue
adhesive (CTA); Vetbond, 3M, Loughborough, UK];
these include deep stromal ulcers, descemetoceles, small
perforations, lacerations, and refractory corneal ulcers [2].
However, CTA is generally not recommended for corneal
perforations or descemetoceles because of possible ocular
toxicity [3]. Accordingly, it is generally avoided in cases
involving severe corneal problems, such as deep corneal
stromal ulcers, perforations, and impending perforations,
in veterinary clinics. However, the use of CTA for corneal
perforations in humans has been reported for several
decades, and several studies have reported high success rates
for the management of corneal thinning and perforations
using CTA [4]. Corneal perforation can cause profound
vision loss [5] and requires immediate treatment for
preservation of the anatomical integrity of the cornea and
prevention of complications such as secondary glaucoma

or endophthalmitis [5]. There are several methods
for the management of corneal perforation; of these,
bandage contact lens insertion and gluing are temporary
methods. However, if the patient cannot undergo surgery
for a variety of reasons, these methods are inevitably
used as permanent treatment methods. Moreover, CTA
application is relatively inexpensive and does not require
systemic anesthesia. Therefore, the usefulness and safety of
CTA application for the management of corneal diseases
in dogs that cannot undergo surgery should be explored.
To the best of our knowledge, the use of CTA for the
management of corneal perforation in patients who could
not be operated on because of poor systemic condition has
not been described previously. Herein, we describe such
cases in three dogs.
2. Case history
Case 1 involved a 10-year-old spayed female Shih-Tzu with
a chronic corneal ulcer in the right eye for 2 weeks. This
eye was treated with eye drops at the local animal hospital;
however, the condition worsened and corneal perforation
developed. Initial ophthalmological examination at our
center revealed a deep ulcer measuring 2 mm in diameter
in the center of the cornea and moderate blepharospasm.
A very small perforation was also detected in the temporal
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region of the ulcer; this perforation was already sealed with
a fibrin plug (Figure 1). Severe corneal neovascularization
from the dorsonasal limbus to the corneal ulcer was
also detected (Figure 1). In the fluorescein test, all ulcer
areas were stained except for the perforated area. The
intraocular pressure (IOP) decreased to 10 mmHg, and a
Schirmer tear test showed increased tear production (22
mm/min). The owner also reported fluid discharge for 1
day. The menace response and dazzle reflex were positive.
Because of chronic heart failure, the dog could not receive
systemic anesthesia.
Case 2 involved a 13-year-old spayed female Pekingese
with central corneal perforation in the left eye that

disrupted the shape of the globe. The cornea appeared
wrinkled, and superficial neovascularization was also
present. Ophthalmological examination revealed vision
loss in the left eye, with no menace response or dazzle
reflex. The anterior chamber was shallow, and an aqueous
leak was observed at the perforation site. The perforation
measured 2 mm in diameter and was sealed with a fibrin
plug (Figure 2a). IOP was considerably reduced and could
not be measured. Ultrasonography revealed loss of globe
integrity, and the anterior chamber was not visible (Figure
2b). The retina could not be evaluated because of the
altered globe structure. Because of severe collapse in the
eye due to perforation, we could not perform any further

Figure 1. Initial ophthalmic examination of the right eye in Case 1. A) A very small corneal perforation
is detected in the temporal region of the corneal ulcer, and it is already sealed with a fibrin plug. B) A
close-up view of the ulceration. A very small perforation was detected in the temporal region of the
ulcer (arrow); this perforation was already sealed with a fibrin plug. For better visualization of the
perforated ulcers, the contrast in the original photo has been increased.

Figure 2. Initial ophthalmic examination of the left eye in Case 2. A) The anterior chamber is shallow,
and an aqueous leak can be seen at the perforation site. The perforation measures 2 mm in diameter
and is sealed with a fibrin plug. B) Ultrasonography shows loss of the globe integrity. The anterior
chamber is not visible.
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ophthalmic examination. We recommended emergency
conjunctival grafting; however, physical examination
revealed difficulty in breathing. Radiographic examination
showed aerophagia secondary to dyspnea and right- and
left-sided heart disease. The patient was deemed unfit to
receive general anesthesia.
Case 3 involved a 9-year-old castrated male Shih-Tzu
with central corneal perforation in the left eye. The dog had
a history of glaucoma in the right eye for 2 years and had
undergone chemical ablation with cidofovir. In addition,
it had received treatment for chronic hepatic failure at
several animal hospitals. The left eye had developed a
superficial corneal ulcer that was successfully treated.
Two weeks later, the same eye was subjected to severe
blunt trauma, which resulted in sudden worsening of the
ulcer-related symptoms. Ophthalmological examination
revealed a deep stromal ulcer, severe corneal edema, a
severe ciliary flush, and hypopyon. There was no menace
response or dazzle reflex. A fluorescein test showed a
large stained area (approximately 5 mm) in the center of
the cornea. Considering the history of chronic hepatic
failure, we attempted to treat the eye with levofloxacin
(Cravit, Santen Pharmaceutical Co., Ltd., Japan) and 1.2%
hyaluronate (an-HyPro, An-Vision, Germany). However,
corneal perforation developed 1 week later (Figure 3).
The CTA application procedure in our cases was as
follows. The affected eye was anesthetized with topical
anesthesia (proparacaine, Alcaine, Alcon, Belgium) and
fully irrigated with Hartmann’s solution (Daihan Hartmann’s
Sol., Dai Han Pharm. Co., Ltd., Republic of Korea).
Antibiotic eye drops (Tarivid, Santen Pharmaceutical Co.,

Ltd., Japan) were subsequently instilled. The ulcerated
surface and adjacent epithelium were carefully dried with a
cellulose sponge (Figure 4a), which was also used to debride
some loose epithelium around the area of perforation.
Using a 1-mL syringe with a 26-G hypodermic needle, we
carefully applied a small droplet of CTA (Vetbond) to the
area of perforation (Figure 4b). A compensator prevented
the patient’s head from moving for approximately 30 s; this
allowed the glue to dry partially (Figure 4c). Once the tissue
glue had dried to a certain extent, a very small amount was
reapplied in the manner described above. This prevented the
glue from forming droplets on the corneal surface (Figure
4d). Thus, several layers of CTA were allowed to settle over
the perforated area, and the outermost membrane was
kept as smooth as possible. In addition, we ensured that
the adhesive did not fall on the eyelid. After the procedure,
prophylactic topical antibiotics were applied twice daily for
2 weeks.
3. Results and discussion
All three cases were considered unsuitable for surgery
under general anesthesia. All the patients had very
poor body condition, and they were all brachycephalic
breeds. In these breeds, lagophthalmos is seen as an
anatomical feature of the skull; therefore, the center of
the cornea is exposed, and retention of tears in this area
is difficult. Because of poor body condition, the corneal
epithelialization is also expected to be poor, which would
exacerbate the corneal ulcer.
In Case 1, we decided to use CTA for management
of the ulcer and perforation. After CTA application,

Figure 3. Initial ophthalmic examination of the left eye in Case 3. A) A deep stromal ulcer, severe corneal
edema, and a severe ciliary flush can be seen. Corneal perforation is also detected at the center of the ulcer. B)
Close-up view of the ulceration. This perforation was already sealed with a fibrin plug. For better visualization
of the perforated ulcers, the contrast in the original photo has been increased.
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Figure 4. Method of application of CTA for the management of corneal perforation in dogs. A) The ulcer surface and
adjacent epithelium are carefully dried by a cellulose sponge, which is also used to debride some loose epithelium around
the perforation area. B) A small CTA droplet is carefully applied to the perforation via a needle and syringe (1-mL
syringe with a 26-G hypodermic needle). C) A compensator prevents the patient’s head from moving for approximately
30 s; this allows the glue to dry partially. D) Once the tissue glue has dried to a certain extent, a very small drop is applied
again. This method prevents the glue from forming droplets on the cornea.

we inserted a contact lens (Pure Vision 2, Bausch &
Lomb Inc., USA) and instilled antibiotic and mydriatic
eye drops (Mydrin-P, Santen Pharmaceutical Co., Ltd.,
Japan). The contact lenses had the following parameters:
diameter 14 mm, base curve 8.6 mm, thickness 0.07
mm [6], and they were maintained in the cornea for 6
days to protect the cornea and CTA. Two days later, the
adhesive sloughed and the ulceration site was exposed.
Nevertheless, the blepharospasm had almost resolved
and the conjunctival hyperemia had reduced, although
increased neovascularization and corneal leukosis could
be observed. We reapplied CTA to the area of ulceration
(Figure 5a), and sloughing occurred a week later. Although

the depth of the ulcer remained unchanged, there was no
blepharospasm or ocular discharge. If the CTA sloughed,
we reapplied it. Thus, we maintained CTA in the area of
ulceration for 20 days, following which the ulcer became
shallow and exhibited granulation tissue formation (Figure
5b). CTA application was discontinued, and almost
complete healing with a reduction in the corneal opacity
was observed 42 days after the first application. Corneal
leukosis could be seen around the area of ulceration, and
the neovascularization had almost disappeared (Figure
5c). We administered systemic NSAIDs and antibiotics
for 10 days followed by flurbiprofen eye drops (Ocufen,
Allergan Inc., Irvine, CA, USA) to treat the keratitis and
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uveitis after granulation tissue was detected in the ulcer.
However, we had not used antiinflammatory eye drops the
first time we applied CTA because of the delay in healing
of the corneal ulcer. Antibiotic eye drops were also applied
during treatment.
In Case 2, CTA and antibiotic eye drops were used
for treatment. We administered systemic NSAIDs and
antibiotics for 7 days, followed by systemic steroids
and antibiotics with 1% prednisolone acetate eye drops
(Pred-forte, Allergan Inc., Irvine, CA, USA) for treating
uveitis and retinitis. Two days after CTA application, the
glue sloughed and revealed the perforated site. CTA was
reapplied, and the perforation was sealed a week later. There

was no anterior aqueous leakage, and the corneal stroma
was regenerating under the adhesive. However, severe
anterior synechia was observed. We maintained CTA in
the area of ulceration for 20 days. If the CTA sloughed,
we reapplied it. Three weeks after the first application,
the menace response and dazzle reflex were restored and
the globe exhibited a normal shape on ultrasonography
(Figure 6a). CTA application was discontinued at this
point. During the follow-up period of 3 months, corneal
leukosis developed in the area of ulceration. However, the
ulcer had completely healed, the vision was restored, and
the dog was able to resume normal daily activities (Figure
6b).

Figure 5. Healing after CTA application for the management of corneal perforation in Case 1. A) Two days after CTA application, more
neovascularization and leukosis on the cornea are detected. CTA is reapplied to the area of ulceration. B) Twenty days later, granulation
tissue has formed in the area of ulceration, and the depth of the ulcer has decreased. CTA application was discontinued at this point.
C) Forty-two days later, most of the ulcer has healed and the cornea opacity is resolving. Corneal leukosis is present around the area of
ulceration, while the neovascularization has almost disappeared.

Figure 6. Healing after CTA application for the management of corneal perforation in Case 2.
A) Three weeks later, the globe exhibits a normal shape on ultrasonography. CTA application
was discontinued at this point. B) During the follow-up period of 3 months, corneal leukosis
developed in the area of ulceration. However, the ulcer has completely healed and the vision has
been restored.
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In Case 3, considering the history of chronic hepatic
failure, we decided to use CTA to seal the perforation,
followed by the use of levofloxacin and hyaluronate eye
drops. The patient had been undergoing medical treatment
for a long time due to hepatic failure, and therefore, the
liver was sensitive to steroids and NSAIDs. Liver serum
chemistry had been severely sensitive even with any
antiinflammatory agents. Due to this, the antiinflammatory
treatment was stopped. Five days later, the CTA fell off the
cornea, and the corneal opacity had reduced. Fibrosis and
neovascularization had progressed to the perforated area
(Figure 7a). Although the menace response was negative,
the dog could pass through obstacles in a maze test. Sixteen
days after the first application, the area of perforation was

fully covered with granulation tissue (Figure 7b). The
blepharospasm resolved and the eye could open easily,
with a positive menace response. CTA application was
discontinued. Thirty-two days after the first procedure,
the granulation tissue in the area of perforation began
to disappear, the peripheral neovascularization had
reduced, and the transparency of the corneal periphery
had considerably increased (Figure 7c). One hundred days
after the first CTA application, the neovascularization had
considerably reduced and corneal leukosis due to corneal
fibrosis could be observed. The iris was partially visible
because of the increased transparency of the peripheral
cornea (Figure 7d). The menace response and dazzle reflex
were positive. After 1 year, the keratitis had resolved and

Figure 7. Healing after CTA application for the management of corneal perforation in Case 3. A) Five days after CTA application, the
adhesive has fallen off the cornea and the peripheral corneal opacity has reduced. Fibrosis and neovascularization have progressed to the
perforated area. B) Sixteen days later, the area of perforation is fully covered with granulation tissue. CTA application was discontinued at this
point. C) Thirty-two days after the procedure, the granulation tissue in the area of perforation begins to disappear, the neovascularization
at the edges of the cornea has reduced, and the transparency of the corneal periphery has considerably increased. D) After 100 days, the
neovascularization has further reduced, while corneal leukosis has developed because of corneal fibrosis. The iris is partially visible because
of increased transparency of the peripheral cornea. The menace response and dazzle reflex were positive at this point.
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the cornea appeared healthy with a further increase in
transparency.
In veterinary medicine, corneal perforations are
managed with more conventional methods such as
direct suturing and conjunctival grafts [7]. Because the
toxicity caused by CTA can seriously affect the structure
of the eye, the use of this adhesive is contraindicated
in cases involving severe corneal ulcers, such as those
with perforations or descemetoceles [8]. When CTA
is applied to the cornea, it primarily affects the corneal
endothelium and lens because it comes into direct contact
with these structures [8]. Moreover, instillation of CTA
into the anterior chamber can result in polymerization
of the corneal endothelium and endothelial cell loss [8].
Therefore, this adhesive should be cautiously used for the
management of corneal perforations. However, corneal
perforation requires urgent treatment and is likely to
result in vision loss if not treated in a timely and adequate
manner. When general anesthesia is contraindicated
for various reasons, it is difficult to find an appropriate
strategy to manage corneal perforation. In such cases,
the perforation can be burnt without general anesthesia.
All three dogs reported here were contraindicated for
surgery under general anesthesia, which was not accepted
by the owners as well. Moreover, Cases 2 and 3 exhibited
vision loss before treatment. It should be noted that CTA
application is associated with some restrictions. According
to several studies, the maximum lesion width suitable
for the application of tissue adhesives is <3 mm [9]. In
the present cases, the perforations measured <3 mm in
diameter. CTA, being nonbiodegradable, may induce
an inflammatory reaction, corneal neovascularization,
a foreign body reaction, and tissue necrosis [9].
Neovascularization became more severe after CTA
application in our cases, resulting in granularization of
the ulcer site. Moreover, corneal leukosis developed after
the ulcerated area was restored. However, the leukosis
developed locally at the ulceration site, and the opacity
considerably reduced as the ulcer healed. In addition,
the abundant superficial vessels formed as a result of
corneal neovascularization decreased with resolution

of the keratitis. Although the exaggerated corneal
vascularization during the healing process increased
the severity of corneal leukosis in all cases, we believe it
was useful for treating the perforations. Once the ulcer
healed and keratitis disappeared, this vascularization,
along with the leukosis, reduced considerably. Because
CTA is not biodegradable, it may interfere with corneal
healing. Fibrin glues may be less toxic; however, they are
not readily available [8]. In our experience, as fibrin glue
is too slow to form an adhesive plug formation, it was
almost impossible to apply without sedation or general
anesthesia. CTA reportedly stays for 2–3 weeks if applied
well [7]. In our cases, the glue did not remain for 2 weeks
after the first application, probably because of aqueous
humor leakage or frequent application of eye drops.
Consequently, we applied CTA several times. The CTA
treatment was sufficient to treat the perforations, and no
further surgical intervention was required in any case
[10]. During the CTA procedure, the fluorescein test was
not useful because the entire ulcer area was completely
covered with CTA and the ulcer area was not exposed. In
general, it was confirmed that granularization in the ulcer
area occurred after about 20 days of CTA application,
and then CTA application was stopped. From this time,
we considered the fluorescein test to be useless because of
granularization. However, to the best of our knowledge,
there are no studies concerning CTA application to treat
corneal perforations in dogs.
In summary, we have described the use of CTA for the
management of corneal perforations measuring <3 mm in
dogs. Although the CTA sloughed off the cornea during
the initial few days after application, it was maintained
well once the affected site began to heal. All perforations
showed satisfactory healing after 3 to 4 weeks. After
keratitis disappeared, the corneal transparency increased,
neovascularization reduced, and visual acuity returned to
normal. Our findings suggest that CTA application can be
safely used for the management of corneal perforation (<3
mm) in dogs that cannot undergo surgery with cosmetic
outcomes that are better than those achieved with
conventional treatments (e.g., conjunctival grafts).
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